Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Passiglia

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Expert Opinion on Biological Therapy|September 25, 2014
Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenarioGiuseppe Bronte, Giovanni Sortino, Francesco Passiglia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2020
KRAS inhibition in non-small cell lung cancer: Past failures, new findings and upcoming challengesFrancesco Passiglia, Umberto Malapelle, Marzia Del Re, et al.
Translational Lung Cancer Research|August 25, 2021
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?-a trial-level meta-analysis in PD-L1 selected subgroupsFrancesco Passiglia, Antonio Galvano, Valerio Gristina, et al.
Expert Opinion on Investigational Drugs|October 13, 2015
Entrectinib: a potent new TRK, ROS1, and ALK inhibitorChristian Rolfo, Rossana Ruiz, Elisa Giovannetti, et al.
Cancer Treatment Reviews|November 10, 2021
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizonFrancesco Passiglia, Valentina Bertaglia, Maria Lucia Reale, et al.
Therapeutic Advances in Medical Oncology|May 31, 2016
Nintedanib in NSCLC: evidence to date and place in therapyGiuseppe Bronte, Francesco Passiglia, Antonio Galvano, et al.
World Journal of Gastroenterology|September 14, 2016
Multisciplinary management of patients with liver metastasis from colorectal cancerKathleen De Greef, Christian Rolfo, Antonio Russo, et al.
Journal of the American Board of Family Medicine : JABFM|January 9, 2015
Improvement in lung cancer outcomes with targeted therapies: an update for family physiciansChristian Rolfo, Francesco Passiglia, Marcin Ostrowski, et al.
Lung Cancer (Amsterdam, Netherlands)|May 7, 2025
Therapeutic management of patients with advanced thymic malignancies: A review for cliniciansValeria Pavese, Federica Maria Carfì, Enrica Capelletto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 18, 2023
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and RealityGiovanni Farinea, Veronica Crespi, Angela Listì, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Expert Opinion on Biological Therapy|September 25, 2014
Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenarioGiuseppe Bronte, Giovanni Sortino, Francesco Passiglia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2020
KRAS inhibition in non-small cell lung cancer: Past failures, new findings and upcoming challengesFrancesco Passiglia, Umberto Malapelle, Marzia Del Re, et al.
Translational Lung Cancer Research|August 25, 2021
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?-a trial-level meta-analysis in PD-L1 selected subgroupsFrancesco Passiglia, Antonio Galvano, Valerio Gristina, et al.
Expert Opinion on Investigational Drugs|October 13, 2015
Entrectinib: a potent new TRK, ROS1, and ALK inhibitorChristian Rolfo, Rossana Ruiz, Elisa Giovannetti, et al.
Cancer Treatment Reviews|November 10, 2021
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizonFrancesco Passiglia, Valentina Bertaglia, Maria Lucia Reale, et al.
Therapeutic Advances in Medical Oncology|May 31, 2016
Nintedanib in NSCLC: evidence to date and place in therapyGiuseppe Bronte, Francesco Passiglia, Antonio Galvano, et al.
World Journal of Gastroenterology|September 14, 2016
Multisciplinary management of patients with liver metastasis from colorectal cancerKathleen De Greef, Christian Rolfo, Antonio Russo, et al.
Journal of the American Board of Family Medicine : JABFM|January 9, 2015
Improvement in lung cancer outcomes with targeted therapies: an update for family physiciansChristian Rolfo, Francesco Passiglia, Marcin Ostrowski, et al.
Lung Cancer (Amsterdam, Netherlands)|May 7, 2025
Therapeutic management of patients with advanced thymic malignancies: A review for cliniciansValeria Pavese, Federica Maria Carfì, Enrica Capelletto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 18, 2023
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and RealityGiovanni Farinea, Veronica Crespi, Angela Listì, et al.
Pageof 13